25
Participants
Start Date
January 31, 2012
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
Lacosamide
Lacosamide will be given orally in 50 mg tablets twice a day for 7 days. The dose will increase weekly by 100 mg per day to a target dose of 300 mg per day. Once the target dose of 300 mg per day has been achieved for 9 days, a 2-day tapering of Lacosamide will occur by 100 mg per day.
005, Little Rock
003, Cleveland
004, Austin
001, Fredericksburg
Lead Sponsor
UCB Pharma
INDUSTRY